Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company Mitsubishi Tanabe Pharma Corp.
DescriptionPhosphodiesterase-4 (PDE-4) inhibitor
Molecular Target Phosphodiesterase-4 (PDE-4)
Mechanism of ActionPhosphodiesterase-4 (PDE-4) inhibitor
Therapeutic Modality 
Latest Stage of DevelopmentPhase II
Standard IndicationDermatitis
Indication DetailsTreat atopic dermatitis
Regulatory Designation
PartnerMaruho Co. Ltd.

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today